Vimarsana
Biggest News Aggregation in the World

Translational Psychedelic Research Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Translational Psychedelic Research Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Translational Psychedelic Research Program Today - Breaking & Trending Today

The controversial trend of microdosing is growing among young mothers - Vimarsana News

The controversial trend of microdosing is growing among young mothers

Some mothers say microdosing helps them feel happy

Source: wdsu.com
A California panel is holding up studies on psychedelics. Some researchers want it gone. - Vimarsana News

A California panel is holding up studies on psychedelics. Some researchers want it gone.

Across California, dozens of medical studies are in limbo thanks to a little-known government panel that monitors research on federally restricted drugs and addiction treatment.

A California panel is holding up studies on psychedelics. Some researchers want it gone - Vimarsana News

A California panel is holding up studies on psychedelics. Some researchers want it gone

Across California, dozens of such studies are in limbo thanks to a little-known government panel that monitors research on federally restricted drugs and addiction treatment.

A California panel is holding up studies on psychedelics. Some researchers want it gone - Vimarsana News

A California panel is holding up studies on psychedelics. Some researchers want it gone

Across California, dozens of such studies are in limbo thanks to a little-known government panel that monitors research on federally restricted drugs and addiction treatment.

A California panel is holding up studies on psychedelics. Some researchers want it gone - Vimarsana News

A California panel is holding up studies on psychedelics. Some researchers want it gone

Across California, dozens of such studies are in limbo thanks to a little-known government panel that monitors research on federally restricted drugs and addiction treatment.